Top 5 Drug And Medical Device Developments Of 2019

Law360 (January 9, 2020, 4:35 PM EST) -- As we settle into both a new year and a new decade, we pause, once again, to reflect on the developments in drug and device law last year. Below is a brief recap and assessment of our top five developments for 2019.

1. Developments in Opioid Litigation

Developments in opioid litigation have received extensive coverage this year, a product of the over 2,000 lawsuits filed in the ongoing opioid multidistrict litigation. From the announcement of opioid-manufacturer Purdue Pharma LP’s bankruptcy filing in September to attempts to disqualify -U.S. District Judge Dan Aaron Polster three weeks before the bellwether trial’s scheduled start, coverage of opioid...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS